Market Research Logo

Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review

Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, immune disorders and rare diseases, besides vaccines. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells prescription medicines through wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. It sells consumer healthcare products through pharmacies, retail chains, distributors and grocery and convenience stores. The company provides its products in the North America, South America, Asia-Pacific, Australia, Europe, Africa and the Middle East. Pfizer is headquartered in New York, the US.

Pfizer Inc Key Recent Developments

Mar 19,2018: BioDuro Collaboration with Pfizer Leads to Creation of a Shelf-Stable Fluorosulfation Reagent
Mar 06,2018: Pharmaceutical company Pfizer and Swansea University drive forward collaboration at BioWales 2018
Mar 05,2018: Pfizer Names Dan R. Littman As Board Director
Feb 23,2018: Pfizer Appoints Albert Bourla As Board Director
Feb 13,2018: BC Platforms to Provide Real World Evidence Solutions to Pfizer in Cardiovascular Diseases

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Pfizer Inc - Key Facts
Pfizer Inc - Key Employees
Pfizer Inc - Key Employee Biographies
Pfizer Inc - Major Products and Services
Pfizer Inc - History
Pfizer Inc - Company Statement
Pfizer Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Pfizer Inc - Business Description
Business Segment: Essential Health (EH)
Overview
Performance
Business Segment: Innovative Health (IH)
Overview
Performance
Geographical Segment: Developed Europe (includes Western Europe, Scandinavian countries and Finland)
Performance
Geographical Segment: Developed Rest of World (includes Australia, Japan, Canada, South Korea and New Zealand)
Performance
Geographical Segment: Emerging Markets (includes, but is not limited to, Asia (excluding Japan and South Korea), Eastern Europe, Latin America, Africa, Central Europe, the Middle East and Turkey)
Performance
Geographical Segment: The US
Performance
R&D Overview
Pfizer Inc - Corporate Strategy
Pfizer Inc - SWOT Analysis
SWOT Analysis - Overview
Pfizer Inc - Strengths
Pfizer Inc - Weaknesses
Pfizer Inc - Opportunities
Pfizer Inc - Threats
Pfizer Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Pfizer Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 19, 2018: BioDuro Collaboration with Pfizer Leads to Creation of a Shelf-Stable Fluorosulfation Reagent
Mar 06, 2018: Pharmaceutical company Pfizer and Swansea University drive forward collaboration at BioWales 2018
Feb 13, 2018: BC Platforms to Provide Real World Evidence Solutions to Pfizer in Cardiovascular Diseases
Feb 07, 2018: NetVation DL Medicine enters into research collaboration with Pfizer
Feb 07, 2018: NetVation DL Medicine enters into research collaboration with Pfizer
Feb 02, 2018: The Breast Cancer Research Foundation Announces the Expansion of the Drug Research Collaborative to Better Understand Potential Treatment Pathways for Breast Cancer Patients
Feb 02, 2018: BCRF Announces Expansion of the Drug Research Collaborative
Jan 30, 2018: Pfizer Reports Fourth-Quarter And Full-Year 2017 Results
Jan 30, 2018: NIH launches partnership to improve success of clinical trials for patients with Parkinson’s disease
Jan 11, 2018: Pfizer Announces Neuroscience R&D Decision Update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Pfizer Inc, Key Facts
Pfizer Inc, Key Employees
Pfizer Inc, Key Employee Biographies
Pfizer Inc, Major Products and Services
Pfizer Inc, History
Pfizer Inc, Subsidiaries
Pfizer Inc, Joint Venture
Pfizer Inc, Key Competitors
Pfizer Inc, Ratios based on current share price
Pfizer Inc, Annual Ratios
Pfizer Inc, Annual Ratios (Cont...1)
Pfizer Inc, Annual Ratios (Cont...2)
Pfizer Inc, Interim Ratios
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Pfizer Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Pfizer Inc, Performance Chart (2013 - 2017)
Pfizer Inc, Ratio Charts
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Pfizer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report